Wednesday, February 22, 2012

August 17, 2013

I divided the final list of augmentations into two categories: those that fall within 12,5% lethal/malformation tolerances, and those with higher failure rates or long-term side-effects that we haven’t adequately studied.
 

v  Accepted protocols:

Ø  1. Occipital capillary reversal
Submergence and boosted blood vessel flow beneath the rods and cones of the subject’s retina.  Produces a marked visual perception increase.

§  Risk: 11% have retinal rejection and detachment.  Permanent blindness.

Ø  2. Muscular enhancement injections
Protein complex is injected intramuscularly to increase tissue density and decrease lactase recovery time.

§  Risk: 5% of test subjects experience fatal cardiac volume increase.

Ø  3. Carbide ceramic ossification
Advanced material grafting onto skeletal structures to make bones virtually unbreakable.  Recommended coverage not to exceed 3% total bone mass because of significant white blood cell necrosis.

§  Risk: 3.8% FAIL rate due to possible mutations and compromised matrix/marrow integrity.  Specific risk for pre- and near-postpubescent adolescents: skeletal growth spurts may cause irreparable bone pulverization.

Ø  4. Catalytic thyroid implant
Platinum pellet containing human growth hormone catalyst is planted in the thyroid to boost growth of skeletal and muscle tissues.

§  Risk: 2% acquire elephantiasis.  Suppressed sexual drive.

Ø  5. Super conducting fibrification of neural derdrites
Significantly increases reflexes.  Increase in intelligence and memory.

§  Risk: 12% contract Parkinson’s disease and Fletcher’s syndrome.


Although the following protocols have unacceptable FAIL rates, they show promise, and may, with future research, be designed within acceptable tolerances.


§  Adrenal thermal metabolase
Enhances adrenal response under physiological distress.  Catalyst, however, breaks down into highly toxic waste products making this protocol eventually fatal.

o   Future research: Possible coenzyme inhibitor?

§  Cyclo-synthetic neural transmission gene sequences
Significant evidence to support increases in intelligence and cognitive markers.  Very high rate of psychotic and antisocial behavior absolutely prohibits the use of this protocol on any patient.

o   Future research: Gradual application over the subject’s early life mitigates side effects? (Long-term studies being quietly arranged; see notes on Operation: TENDRIL.)

§  Leucocytic coprotein complex and microfibrin spindlase
Wound suppression and near instant blood clotting of vascular breaches.  33% of subjects incur fatal clotting.

o   Future research: Unknown

§  Neuron surface viral microphages
Site injection on neural tissues boosts selenium fiber bonding by three orders of magnitude.  Subsequent appliances fall well within acceptable signal-to-noise ratios, making cybernetic augmentation and integration possible.  FAIL rate Unknown, but I am loathe to manipulate neural parameters without more detailed studies.

o   Future research: Pending



Plus, there’s always the Keres strain.


We start the augmentation phase tomorrow.


If only there was a god to pray to.

No comments:

Post a Comment